These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24397907)

  • 1. Macrolide treatment in patients with bronchiectasis: more attention should be paid to the number of exacerbations.
    Gao YH; Guan WJ; Xu G; Chen RC
    Pulm Pharmacol Ther; 2014 Apr; 27(2):213-4. PubMed ID: 24397907
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "Letter to the Editor" by Serisier regarding "effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review".
    Shi ZL; Peng H; Hu JG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):180-1. PubMed ID: 24731870
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of macrolide maintenance therapy for prevention of disease exacerbations in patients with noncystic fibrosis bronchiectasis.
    Wang D; Fu W; Dai J
    Medicine (Baltimore); 2019 Apr; 98(17):e15285. PubMed ID: 31027086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
    King P
    Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter to the editor: inaccurate data in meta-analysis of macrolides by Shi et al.
    Serisier DJ
    Pulm Pharmacol Ther; 2014 Aug; 28(2):179. PubMed ID: 24412272
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review.
    Shi ZL; Peng H; Hu XW; Hu JG
    Pulm Pharmacol Ther; 2014 Aug; 28(2):171-8. PubMed ID: 24076368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antiinflammatory therapy and macrolides in bronchiectasis.
    Feldman C
    Clin Chest Med; 2012 Jun; 33(2):371-80. PubMed ID: 22640852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term use of macrolides in patients with non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled trials.
    Fan LC; Lu HW; Wei P; Ji XB; Liang S; Xu JF
    BMC Infect Dis; 2015 Mar; 15():160. PubMed ID: 25888483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application progress of macrolide sustained therapy for bronchiectasis].
    Fan L; Xu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):48-50. PubMed ID: 24694975
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term macrolides for non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Wu Q; Shen W; Cheng H; Zhou X
    Respirology; 2014 Apr; 19(3):321-9. PubMed ID: 24417869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
    Gao YH; Guan WJ; Xu G; Tang Y; Gao Y; Lin ZY; Lin ZM; Zhong NS; Chen RC
    PLoS One; 2014; 9(3):e90047. PubMed ID: 24603554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolides for Clinically Significant Bronchiectasis in Adults: Who Should Receive This Treatment?
    Hill AT
    Chest; 2016 Dec; 150(6):1187-1193. PubMed ID: 27591924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is there a role for prophylactic antibiotic treatment with macrolides in bronchiectasis?].
    Bochet M; Garin N; Janssens JP; Gerstel E
    Rev Med Suisse; 2011 Feb; 7(280):308, 310-2. PubMed ID: 21381275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment options for bronchiectasis.
    Metersky ML
    Ther Adv Respir Dis; 2010 Apr; 4(2):93-9. PubMed ID: 20388725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V; Bosnar M; Kragol G
    Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological treatment options for bronchiectasis: focus on antimicrobial and anti-inflammatory agents.
    Ilowite J; Spiegler P; Kessler H
    Drugs; 2009; 69(4):407-19. PubMed ID: 19323585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evidence base for non-CF bronchiectasis is finally evolving.
    Serisier DJ
    Respirology; 2014 Apr; 19(3):295-7. PubMed ID: 24620757
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on Zhuo et al.: prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Li M; Jiang D; Yu S; Wang Y; Wang Y
    Pulm Pharmacol Ther; 2015 Feb; 30():93-5. PubMed ID: 25549569
    [No Abstract]   [Full Text] [Related]  

  • 20. Inaccurate data in meta-analysis of macrolides by Guang-Ying et al.
    Serisier DJ
    Pulm Pharmacol Ther; 2014 Oct; 29(1):89. PubMed ID: 24835168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.